Add ex-Waxmanite to FDA hopefuls list

Yet another candidate for FDA commish in the new Obama world? According to the WSJ Health Blog, ex-adviser to Rep. Henry Waxman Joshua Sharfstein, now commissioner of the Baltimore City Health Department, could be on the list. Report

Suggested Articles

It's taken years for Amarin's Vascepa to prove itself as a game-changing treatment for CV disease. An FDA committee may have just punched its pass.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

With a potential approval next year in the up-and-coming NASH field, Intercept is staffing up its sales team and starting talks with payers.